Bgm (BGM) Intangibles (2019 - 2025)
Bgm's (BGM) quarterly Intangibles came in at $4.5 million in Q3 2025, down 1.14% year-on-year from $4.5 million in Q3 2024, and down 2.15% on a QoQ basis from $4.6 million in Q1 2025.
Bgm (BGM) Intangibles (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Intangibles data on file, last reported at $4.5 million in Q3 2025.
- On a quarterly basis, Intangibles fell 1.14% year-over-year to $4.5 million in Q3 2025; TTM through Sep 2025 was $4.5 million, a 1.14% decrease from a year earlier, with the FY2025 full-year figure at $4.5 million, down 1.14% from the prior year.
- Intangibles for Q3 2025 stood at $4.5 million, down from $4.6 million in the prior quarter.
- Over the last five years, Intangibles for BGM reached as high as $3679.8 billion in Q1 2023 and fell as low as $1.7 million in Q3 2022.
- Historically, Intangibles has averaged $750.5 billion across 5 years, with a median of $4.5 million in 2024.
- Across the five-year window, Intangibles jumped 98.25% in 2023 and slumped 100.0% in 2024, its largest moves.
- Year by year, Intangibles stood at $1.9 million in 2021, then declined by 10.43% to $1.7 million in 2022, then soared by 98.25% to $3.4 million in 2023, then soared by 32.59% to $4.5 million in 2024, then declined by 1.14% to $4.5 million in 2025.
- Per Business Quant data, the three most recent Intangibles figures were $4.5 million in Q3 2025, $4.6 million in Q1 2025, and $4.5 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 5.29 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | 4.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.49 Mn |
| Mar 31, 2025 | 4.59 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Sep 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 3,679.79 Bn |
| Sep 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1,899.18 Bn |
| Sep 30, 2021 | 1.93 Mn |
| Mar 31, 2021 | 1,925.97 Bn |
| Sep 30, 2020 | 1.88 Mn |
| Sep 30, 2019 | 1.83 Mn |